Wang et al. (2018) demonstrated that TFAP2C enhances stemness and chemoresistance to 5-FU in CRC cells by suppressing Hippo signaling via the transcriptional activation of ROCK1 and ROCK2 (26). The gene discussed is ROCK1; the disease is colorectal carcinoma.